| 000 | 01893 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250512022412.0 | ||
| 264 | 0 | _c19881221 | |
| 008 | 198812s 0 0 eng d | ||
| 022 | _a0004-0010 | ||
| 024 | 7 |
_a10.1001/archsurg.1988.01400360072012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrayman, K L | |
| 245 | 0 | 0 |
_aProphylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial. _h[electronic resource] |
| 260 |
_bArchives of surgery (Chicago, Ill. : 1960) _cDec 1988 |
||
| 300 |
_a1502-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _ximmunology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGraft Survival _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney _ximmunology |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aVaccination |
| 700 | 1 | _aDafoe, D C | |
| 700 | 1 | _aSmythe, W R | |
| 700 | 1 | _aBarker, C F | |
| 700 | 1 | _aPerloff, L J | |
| 700 | 1 | _aNaji, A | |
| 700 | 1 | _aFox, I J | |
| 700 | 1 | _aGrossman, R A | |
| 700 | 1 | _aJorkasky, D K | |
| 700 | 1 | _aStarr, S E | |
| 773 | 0 |
_tArchives of surgery (Chicago, Ill. : 1960) _gvol. 123 _gno. 12 _gp. 1502-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archsurg.1988.01400360072012 _zAvailable from publisher's website |
| 999 |
_c2853550 _d2853550 |
||